2026-03-12T17:23:28-05:00 2025-06-30 390859910 BAKER TILLY ADVISORY GROUP LP 601 W RIVERSIDE AVENUE STE 1800 SPOKANE WA 99201 990 2024-07-01 916057438 NORTHWEST KIDNEY CENTERS NORT 2062922771 12901 20TH AVENUE S SEATAC WA 98168 JENNIFER ESLAVA VICE PRESIDENT OF FINANCE/CFO 2062922771 2026-03-11 1 1 EMINA O CRESSWELL P01217304 5097472600 2026-03-11 2024 2025-03-06 01:10:19Z REBECCA FOX 12901 20TH AVENUE S SEATAC WA 98168 168329010 0 X WWW.NWKIDNEY.ORG X 1962 WA TO PROMOTE THE OPTIMAL HEALTH, QUALITY OF LIFE AND INDEPENDENCE OF PEOPLE WITH KIDNEY DISEASE THROUGH PATIENT CARE, EDUCATION, AND RESEARCH. 11 10 1038 531 0 0 1820437 1761404 137404413 145779472 3635444 1177816 -1270203 402765 141590091 149121457 373956 56591 0 0 79920846 81070886 0 0 1046286 59850937 62665968 140145739 143793445 1444352 5328012 292404866 288901658 119381576 105581321 173023290 183320337 X NORTHWEST KIDNEY CENTERS' (NKC) MISSION IS TO PROMOTE THE OPTIMAL HEALTH, QUALITY OF LIFE AND INDEPENDENCE OF PEOPLE WITH KIDNEY DISEASE THROUGH PATIENT CARE, EDUCATION AND RESEARCH. NORTHWEST KIDNEY CENTERS IS A NOT-FOR-PROFIT, LOCALLY MANAGED PROVIDER OF KIDNEY DIALYSIS, PUBLIC HEALTH EDUCATION AND RESEARCH INTO THE CAUSES AND TREATMENTS OF CHRONIC KIDNEY DISEASE. FOUNDED IN SEATTLE IN 1962, IT WAS THE WORLD'S FIRST DIALYSIS ORGANIZATION. AMONG THE EIGHTH LARGEST DIALYSIS PROVIDERS IN THE COUNTRY, IT IS AN INFLUENTIAL MODEL BECAUSE OF ITS HIGH-QUALITY SERVICES, DEEP COMMUNITY CONNECTIONS AND GENEROUS DONOR SUPPORT. 0 0 117211091 146303200 IN THE YEAR ENDED JUNE 30, 2025, NORTHWEST KIDNEY CENTERS PROVIDED 285,069 DIALYSIS TREATMENTS, ESSENTIAL TO SUSTAIN THE LIVES OF PEOPLE WITH KIDNEY FAILURE. NKC SERVED A TOTAL OF 2,676 PATIENTS. THE ORGANIZATION PROVIDED PATIENT CARE IN TWENTY (20) FREE-STANDING CLINICS AND IN EIGHT (8) LOCAL HOSPITALS AND SUPERVISED SELF DIALYSIS TREATMENTS IN THE HOMES OF PATIENTS THROUGHOUT THE COMMUNITY. NKC SPENT OVER $25.8 MILLION MORE ON THE CARE OF PATIENTS WITH MEDICARE AND MEDICAID INSURANCE THAN THE PROGRAMS REIMBURSED US FOR. IN ADDITION, NKC PROVIDED MORE THAN $4.4 MILLION IN CHARITY CARE. NORTHWEST KIDNEY CENTERS' RENAL SPECIALTY PHARMACY, A RARITY IN THE NATION, SERVED MORE THAN 2,174 DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING THE YEAR. 897543 NKC OFFERS FREE CLASSES THAT HELP PEOPLE WITH CHRONIC KIDNEY DISEASE (CKD) PRESERVE KIDNEY FUNCTION, CHOOSE APPROPRIATE TREATMENT, TAKE CARE OF A TRANSPLANTED KIDNEY AND IN GENERAL BE AN EMPOWERED PARTNER IN THEIR KIDNEY HEALTH CARE. THE CLASS PROGRAM PROVIDES OUTREACH TO PEOPLE WHO ARE NOT DIALYSIS PATIENTS AND MAY HELP THEM KEEP THEIR KIDNEYS HEALTHY ENOUGH SO THAT THEY NEVER NEED TO GO ON DIALYSIS OR CAN DELAY ITS ONSET. THE PATIENT-FOCUSED, EVIDENCE-BASED CURRICULUM WAS DEVELOPED BY NORTHWEST KIDNEY CENTERS. THERE WERE 884 CHRONIC KIDNEY DISEASE EDUCATION PARTICIPANTS. IN ADDITION TO ITS FREE CLASSES, NORTHWEST KIDNEY CENTERS CONNECTED WITH 102 COMMUNITY-BASED ORGANIZATIONS, PARTICIPATED IN 45 COMMUNITY EVENTS RESULTING IN 15,725 TOUCHPOINTS WITH PEOPLE THROUGH OUR OUTREACH EFFORTS. 56591 56591 OTHER PROGRAM SERVICES INCLUDE EMERGENCY ASSISTANCE TO NEEDY PATIENTS FOR FOOD, HOUSING AND OTHER EXPENSES. IN FY25, NKC PROVIDED A TOTAL OF $32,609 TO 383 PATIENTS. IN FY25 NKC ALSO PROVIDED 10 EMPLOYEE SCHOLARSHIPS TOTALING $23,982. 118165225 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 88 0 1 1038 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 WA X JENNIFER ESLAVA 2062922771 12901 20TH AVENUE S SEATAC WA 98168 REBECCA FOX CEO & PRESIDENT 50.00 X X 818825 0 61258 DOUG ROSS BOARD CHAIR 1.00 X X 0 0 0 LAUREN GARDNER BOARD VICE CHAIR 1.00 X X 0 0 0 MELODY CRAFF BOARD MEMBER 1.00 X 0 0 0 ANTHONY DORSCH BOARD MEMBER 1.00 X 0 0 0 RICHARD GREAVES BOARD MEMBER 1.00 X 0 0 0 MICHEAL SUTTERS BOARD MEMBER & CONTRACTED MEDICAL DIRECTOR 1.00 X 65874 0 0 QUITA HIGHSMITH BOARD MEMBER 1.00 X 0 0 0 KARISSA MARKER BOARD MEMBER 1.00 X 0 0 0 SHIKA PAPPOE BOARD MEMBER 1.00 X 0 0 0 HINA PATEL BOARD MEMBER 1.00 X 0 0 0 SANJIT REDDY MD BOARD MEMBER 1.00 X 0 0 0 JENNIFER BRENNER BOARD MEMBER (THRU 6/25) 1.00 X 0 0 0 JENNIFER ESLAVA VP OF FINANCE & CFO 50.00 X 428807 0 40754 ROBIN LARMER VP OF LEGAL AFFAIRS (THRU 4/25) 50.00 X 358400 0 22764 MATTHEW RIVARA CHIEF MEDICAL OFFICER 50.00 X 455168 0 17250 HEATHER THOMASSON VP PATIENT CARE SERVS/CHIEF NURSING OFFICER 50.00 X 294646 0 39319 SARAH CORDEIRO VP OF BUSINESS DEV. (THRU 3/25) 50.00 X 264349 0 41973 MARSHA HEATON VICE PRESIDENT OF DEVELOPMENT 50.00 X 238957 0 32066 MICHAEL KELLOGG SR DIRECTOR FACILITY PLANNING 50.00 X 234655 0 68218 TODD BUI REGISTERED NEPHROLOGY NURSE 50.00 X 250136 0 30883 KAREN SCHARTMAN INTERIM VP OF HR (THRU 1/25) 50.00 X 201000 0 0 3610817 0 354485 204 0 1 0 NEWAY 11757 W KEN CARYL AVE SUITE F 106 LITTLETON CO 80127 LABORATORY SERVICES 1197171 ASCEND CLINICAL LLC PO BOX 45021 SAN FRANCISCO CA 941450021 LABORATORY SERVICES 755535 DAVIS WRIGHT TREMAINE LLP PO BOX 7410478 CHICAGO IL 606740478 LEGAL SERVICES 198848 CLARK NUBER PS 555 110TH AVE NE BELLEVUE WA 98004 ACCOUNTING SERVICES 169527 HEALTHCARE SUPPORT STAFFING LLC 101 SOUTHHALL LANE MAITLAND FL 32751 STAFFING SERVICES 129635 8 618737 1142667 78155 1761404 DIALYSIS 621400 124921686 124921686 PAITENT LAB REVENUE 621500 20854914 20854914 INSUR PREMIUM REIMBURS 621400 2872 2872 145779472 1728253 1728253 131776 0 131776 131776 131776 15110000 14496792 1163645 613208 -1163645 -550437 -550437 96318 618737 374807 -278489 -278489 25750 0 25750 25750 3647580 3172309 475271 475271 REIMBURSEMENTS 900099 48457 48457 48457 149121457 146303200 0 1056853 56591 56591 2576031 2011122 538137 26772 64433510 50303609 13460267 669634 2310635 1913107 377020 20508 6044900 4636719 1359187 48994 5705810 4625056 1022542 58212 1870516 1866133 4383 149338 149338 169017 169017 55000 55000 155141 155141 4831301 2681005 2021293 129003 96637 14633 57530 24474 2232852 2024471 205997 2384 5373293 4654177 677868 41248 9355148 9375139 -23647 3656 292478 172712 109279 10487 55382 34530 20621 231 2103171 2103171 7025765 6878015 144008 3742 515410 155439 359971 SUPPLIES 20192928 20068933 123995 BAD DEBT EXPENSE 3693671 3693671 LAB TESTING 1030081 1024955 5126 TAXES & LICENSES 673627 318444 353480 1703 2795212 1656764 1133210 5238 143793445 118165225 24581934 1046286 10885521 10592640 713552 1249392 224937 189380 27418075 31177541 1263718 1458901 1529525 1676352 272125139 104217101 161091557 167908038 71596353 63251414 17681628 11398000 292404866 288901658 20811814 16440768 50010 0 201204 191587 78822627 76939367 19495921 12009599 119381576 105581321 X 167637269 177481070 5386021 5839267 173023290 183320337 292404866 288901658 X 5328012 4813169 6685 149181 X 0 1 X 1 0 X 4755799 5190539 1953543 1820437 1761404 15481722 126078883 127518165 132783036 140940949 149427052 676748085 130834682 132708704 134736579 142761386 151188456 692229807 29387 47050 77908 87376 196797 438518 0 29387 47050 77908 87376 196797 438518 691791289 1220626 1389334 2912553 3295073 1860029 10677615 1220626 1389334 2912553 3295073 1860029 10677615 13412 58330 25489 57430 48457 203118 132068720 134156368 137674621 146113889 153096942 703110540 0.98390 0.98420 0.01520 0.01510 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2020 AMOUNT: $ 308. 2021 AMOUNT: $ 124. 2022 AMOUNT: $ 204. 2023 AMOUNT: $ 242. 2024 AMOUNT: $ 0. REIMBURSEMENTS - 2020 AMOUNT: $ 10,992. 2021 AMOUNT: $ 58,206. 2022 AMOUNT: $ 25,285. 2023 AMOUNT: $ 57,188. 2024 AMOUNT: $ 48,457. CONSIGNMENT - 2020 AMOUNT: $ 2,112. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 0 1 0 1 30000 1 25000 0 0 55000 0 PART II-B, LINE 1: NORTHWEST KIDNEY CENTERS ENGAGED IN LOBBYING AT THE STATE AND FEDERAL LEVEL DURING THE FISCAL YEAR ENDED 6/30/25. GRANTS TO ORGANIZATIONS FOR LOBBYING PURPOSES INCLUDE PAYMENTS TO KIDNEY RELATED LOBBYING ORGANIZATIONS. NORTHWEST KIDNEY CENTERS ACTIVELY WORKS WITH INDUSTRY ORGANIZATIONS SUCH AS NKCA (NON-PROFIT KIDNEY CARE ALLIANCE) AND KCC (KIDNEY CARE COUNCIL) TO WORK WITH POLICY MAKERS AND INDUSTRY REPRESENTATIVES TO GUIDE POLICY AT THE NATIONAL AND STATE LEVELS. 7520141 17440 761911 292012 8007480 7215578 11558 587165 294160 7520141 7076690 18377 408191 287680 7215578 8359321 17146 -1021170 278607 7076690 7089980 17221 1520344 268224 8359321 0.53000 0.34000 0.13000 0 0 23177915 23177915 138853795 21317135 117536660 52359284 39577642 12781642 57513050 43322324 14190726 221095 221095 167908038 DEFERRED COMPENSATION 195757 DEFERRED RENT 175724 LEASE LIABILITY 11638118 12009599 X 153788796 4813169 6685 3696297 8516151 145272645 155141 3693671 3848812 149121457 143491749 3547116 3547116 139944633 155141 3693671 3848812 143793445 PART V, LINE 4: ENDOWMENT FUNDS ARE USED FOR A WIDE VARIETY OF PATIENT SUPPORT NEEDS AND KIDNEY RESEARCH, INCLUDING CHRONIC KIDNEY DISEASE PATIENT EDUCATION, TRANSPORTATION SUPPORT TO TREATMENT APPOINTMENTS, TRAINING FOR PATIENTS TO PERFORM DIALYSIS TREATMENTS FROM THEIR HOME, AND ACCESS TO CLINICAL TRIALS THROUGH OUR PARTNERSHIP WITH THE KIDNEY RESEARCH INSTITUTE. PART X, LINE 2: THE ORGANIZATION IS NOT SUBJECT TO INCOME TAX, AS IT IS A TAX-EXEMPT ORGANIZATION UNDER THE INTERNAL REVENUE CODE SECTION 501(C)(3). HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. MANAGEMENT EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THE ORGANIZATION HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRED ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF ASC 740. INCOME TAX RETURNS ARE GENERALLY SUBJECT TO EXAMINATION FOR THREE YEARS AFTER THEY ARE FILED. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT 149,181. PHARMACY COST OF GOODS SOLD REPORTED ON PART VIII 3,172,309. FUNDRAISING EXPENSE 374,807. PART XI, LINE 4B - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 3,693,671. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSE 374,807. PHARMACY COST OF GOODS SOLD REPORTED ON PART VIII 3,172,309. PART XII, LINE 4B - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 3,693,671. GALA 715055 618737 96318 135154 44904 3216 191533 715055 618737 96318 135154 44904 3216 191533 374807 -278489 25750 1 1.00000 25750 25750 WA 1 0 0 0 1.00000 0.00000 JACQUI WEBER 12901 20TH AVENUE S SEATAC WA 98168 0 JACQUI WEBER 0 MAINTAINED ALL RECORDS OF RAFFLE HELD FOR THE ANNUAL GALA. X 1 25750 1 INDIVIDUAL GRANTS 383 32609 SCHOLARSHIPS 10 23982 PART I, LINE 2: INDIVIDUAL GRANTS: THE EMERGENCY FUND PROGRAM PROVIDES SUPPORT FOR SELECT NKC PATIENTS CURRENTLY RECEIVING DIALYSIS, OR PATIENTS OF NKC WHO HAVE RECEIVED A KIDNEY TRANSPLANT WITHIN THE PREVIOUS THREE YEARS AND RESIDE WITHIN WASHINGTON STATE. GRANTS OF UP TO $250 PER PATIENT MAY BE AWARDED IN A GIVEN TWELVE MONTH PERIOD. PAYMENT IS IN THE FORM OF A GROCERY STORE GIFT CARD. REQUESTS FOR LARGER AMOUNTS WILL BE CONSIDERED INDIVIDUALLY ON AN EXCEPTION BASIS. NKC SOCIAL WORKERS ARE RESPONSIBLE FOR OBTAINING DOCUMENTATION OF THE PATIENT'S NEED AND INVESTIGATION OF ALL OTHER POSSIBLE COMMUNITY RESOURCES AVAILABLE TO MEET THE NEED. EACH GRANT MUST BE APPROVED BY THE PATIENT'S SOCIAL WORKER, AND THE SOCIAL SERVICES DIRECTOR. THE GRANT WILL BE PAID TO A THIRD PARTY FOR THE SERVICE OR MATERIAL NEEDED BY THE PATIENT. SCHOLARSHIPS: EMPLOYEE SCHOLARSHIP APPLICATIONS ARE REVIEWED BY DEVELOPMENT STAFF TO ENSURE APPLICATIONS ARE COMPLETE, AND BY HUMAN RESOURCES (HR) TO ENSURE APPLICANTS MEET MINIMUM QUALIFICATIONS (EMPLOYED AT LEAST ONE YEAR, FULL-TIME OR REGULAR PART-TIME (AT LEAST 24 HOURS PER WEEK)). THOSE WHO MEET MINIMUM QUALIFICATIONS ARE SENT TO THE EMPLOYEE SCHOLARSHIP COMMITTEE TO BE RATED USING A SCORING MATRIX OF SPECIFIC CRITERIA. THE COMMITTEE IS COMPRISED OF AN HR REPRESENTATIVE, CKD PROGRAM MANAGER (MSW) AND VP DEVELOPMENT. THE HIGHEST RATED APPLICANTS THEN INTERVIEW WITH THE COMMITTEE. AFTER THAT, THE COMMITTEE DECIDES WHO WILL RECEIVE A SCHOLARSHIP AND HOW MUCH. THE ACTUAL AMOUNTS AWARDED DEPEND ON RESTRICTIONS PLACED BY THE DONORS ABOUT HOW THE SCHOLARSHIP FUNDS CAN BE USED AND THE AMOUNT AVAILABLE IN ANY GIVEN YEAR. X 1 1 X X X X X 0 0 0 0 0 0 0 1 0 REBECCA FOX CEO & PRESIDENT 591308 0 105300 0 122217 0 30482 0 30776 0 880083 0 0 0 MATTHEW RIVARA CHIEF MEDICAL OFFICER 401926 0 44000 0 9242 0 16768 0 482 0 472418 0 0 0 JENNIFER ESLAVA VP OF FINANCE & CFO 351685 0 62550 0 14572 0 23000 0 17754 0 469561 0 0 0 ROBIN LARMER VP OF LEGAL AFFAIRS (THRU 4/25) 281275 0 33600 0 43525 0 12138 0 10626 0 381164 0 0 0 HEATHER THOMASSON VP PATIENT CARE SERVS/CHIEF NURSING OFFICER 261216 0 22100 0 11330 0 10449 0 28870 0 333965 0 0 0 SARAH CORDEIRO VP OF BUSINESS DEV. (THRU 3/25) 222963 0 27757 0 13629 0 23000 0 18973 0 306322 0 0 0 MICHAEL KELLOGG SR DIRECTOR FACILITY PLANNING 234655 0 0 0 0 0 30500 0 37718 0 302873 0 0 0 TODD BUI REGISTERED NEPHROLOGY NURSE 245323 0 0 0 4813 0 30500 0 383 0 281019 0 0 0 MARSHA HEATON VICE PRESIDENT OF DEVELOPMENT 200954 0 18000 0 20003 0 30143 0 1923 0 271023 0 0 0 KAREN SCHARTMAN INTERIM VP OF HR (THRU 1/25) 201000 0 0 0 0 0 0 0 0 0 201000 0 0 0 PART I, LINE 1A NKC PAYS MONTHLY HEALTH AND SOCIAL CLUB DUES FOR THE CEO AND PRESIDENT TO BE UTILIZED TO FURTHER THE INTERESTS OF NKC. THESE BENEFITS ARE NONTAXABLE TO THE CEO AND PRESIDENT. PART I, LINE 7 THE VICE PRESIDENTS PARTICIPATE IN A SHORT-TERM INCENTIVE PLAN DESIGNED TO ENCOURAGE ACHIEVEMENT OF CERTAIN GOALS ALIGNED WITH THE CEO'S GOALS AND RECOGNIZE SPECIAL CONTRIBUTIONS TO NKC'S FINANCIAL AND OPERATIONAL SUCCESS. THE CEO IS RESPONSIBLE FOR ANNUAL REVIEW AND ASSESSMENT OF THE VICE PRESIDENTS' PERFORMANCE TO PRE-DETERMINED GOALS AS WELL AS FINAL DETERMINATION OF SHORT-TERM INCENTIVE AMOUNTS EARNED. THE CEO AND THE VICE PRESIDENTS PARTICIPATE IN A LONG-TERM INCENTIVE PLAN DESIGNED TO ENCOURAGE LONGER TERM STRATEGIC OBJECTIVES. THE STRATEGIC GOALS FOR A THREE YEAR PERIOD ARE REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY. THE COMPENSATION COMMITTEE IS RESPONSIBLE FOR ANNUAL REVIEW AND APPROVAL OF LONG-TERM INCENTIVE AMOUNTS EARNED. THE COMPENSATION COMMITTEE OF THE BOARD HAS BOARD-DELEGATED RESPONSIBILITY FOR ESTABLISHING THE TOTAL COMPENSATION PACKAGE FOR THE CEO, AND APPROVING THE CEO'S COMPENSATION PACKAGE. A WASHINGTON HEALTH CARE FACILITIES AUTHORITY 2021 SERIES A 911108929 2021-05-31 51300000 PREVIOUS PAY OFF, ISSUANCE COSTS 0 0 0 B WASHINGTON HEALTH CARE FACILITIES AUTHORITY 2021 SERIES B 911108929 2021-05-31 28600000 PREVIOUS PAY OFF, CAPITAL IMPROVEMENTS 0 0 0 A 51300000 1190500 50109500 2021 1 0 1 1 B 61023 28600000 27520000 1080000 2021 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 B 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 0 0 0 0 0 0 1 B 0 1 0 0 0 0 0 0 1 A 1 B 1 X 3 30109 MARKET PRICE X AUCTION ITEMS 16 48046 ESTIMATED FAIR VALUE 0 0 1 0 PART I, COLUMN (B): THE NUMBER IN PART I, COLUMN (B) FOR SECURITIES CLOSELY HELD STOCK REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED. THE NUMBER IN PART I, COLUMN (B) FOR OTHER AUCTION ITEMS REPRESENTS THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART 1, LINE 6: NORTHWEST KIDNEY CENTERS IS LED BY A VOLUNTEER BOARD OF TRUSTEES AND BY A FOUNDATION BOARD THAT HELPS RAISE MONEY AND MAKE CONNECTIONS. THEY ARE JOINED BY AN ESTIMATED 500 OTHER VOLUNTEERS AS NEEDED TO STAFF EVENTS FOCUSED ON FUNDRAISING OR THE COMMUNITY. ACCORDING TO OUR RECORDS, DURING FY25, NORTHWEST KIDNEY CENTERS CONNECTED WITH 102 COMMUNITY-BASED ORGANIZATIONS, PARTICIPATED IN 45 COMMUNITY EVENTS RESULTING IN 15,725 TOUCHPOINTS WITH PEOPLE THROUGH OUR OUTREACH EFFORTS. FORM 990, PART VI, SECTION B, LINE 11B FIRST MANAGEMENT THEN THE FINANCE, AUDIT AND INVESTMENT COMMITTEE REVIEWED THE 2024 FORM 990 BEFORE IT WAS FILED. THE 2024 FORM 990 WAS ALSO PROVIDED TO THE FULL BOARD OF TRUSTEES BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES ALL BOARD MEMBERS, BOARD COMMITTEE MEMBERS, OFFICERS, DIRECTORS AND MANAGERS ANNUALLY TO DISCLOSE FINANCIAL INTERESTS AND PERSONAL RELATIONSHIPS WITH POTENTIAL TO GIVE RISE TO A CONFLICT. EACH OF THEM GETS A COPY OF THE CONFLICT OF INTEREST POLICY AND A SURVEY QUESTIONNAIRE ON WHICH THEY ARE REQUIRED TO DETAIL POTENTIAL AND ACTUAL CONFLICTS OF INTEREST. ALL DISCLOSURES ARE REVIEWED BY THE COMPLIANCE OFFICER WHO DETERMINES IF ANY POTENTIAL CONFLICT EXISTS AND RECOMMENDS A MITIGATION PLAN AS NEEDED. THIS INFORMATION IS THEN REPORTED TO AND REVIEWED BY THE BOARD COMPLIANCE COMMITTEE AND THE BOARD GOVERNANCE COMMITTEE. INDIVIDUAL BOARD MEMBERS ARE REMINDED TO ABSTAIN FROM VOTES IF THERE IS A POTENTIAL CONFLICT OF INTEREST. ALL BOARD MEMBERS AND EMPLOYEES RECEIVE TRAINING ABOUT CONFLICTS OF INTEREST AND THE POLICY IS POSTED IN NORTHWEST KIDNEY CENTERS' POLICY MANAGEMENT APPLICATION. FORM 990, PART VI, SECTION B, LINE 15 NORTHWEST KIDNEY CENTERS BOARD OF TRUSTEES' COMPENSATION COMMITTEE REVIEWS THE PRESIDENT/CEO'S COMPENSATION, INCLUDING WITHOUT LIMITATION BASE SALARY, INCENTIVE COMPENSATION, EMPLOYEE BENEFITS AND PERQUISITES. THE COMMITTEE CONSISTS OF FOUR INDEPENDENT BOARD MEMBERS WHO DO NOT RECEIVE ANY COMPENSATION FROM NORTHWEST KIDNEY CENTERS. THE COMMITTEE CONTRACTS WITH AN INDEPENDENT FIRM TO OBTAIN COMPARABILITY DATA AND OTHER INFORMATION NECESSARY TO SET A REASONABLE TOTAL COMPENSATION PACKAGE FOR THE PRESIDENT AND CEO, CONSISTENT WITH THE CORPORATION'S COMPENSATION PHILOSOPHY. THE COMPARABILITY DATA INCLUDES TOTAL COMPENSATION PAID BY SIMILARLY SITUATED ORGANIZATIONS FOR FUNCTIONALLY COMPARABLE POSITIONS RELATIVE TO SIZE, COMPLEXITY, GEOGRAPHY, AND THE NATURE OF THE ORGANIZATION. THE COMPENSATION COMMITTEE IS DELEGATED BY THE BOARD OF TRUSTEES TO APPROVE A SALARY FOR THE PRESIDENT/CEO. THE PROCESS WAS PERFORMED IN 2025 FOR THE COMPENSATION PACKAGE OF THE PRESIDENT/CEO. DATA REGARDING THE VICE PRESIDENTS' PAY HISTORY, CURRENT PAY AND PROPOSED ADJUSTMENTS WERE PROVIDED TO THE NORTHWEST KIDNEY CENTERS COMPENSATION COMMITTEE, WHO DETERMINE THAT SUCH AMOUNTS ARE CONSISTENT WITH MARKET PARAMETERS. COMPENSATION FOR THE VICE PRESIDENTS WAS LAST REVIEWED IN 2025. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S BYLAWS, ARTICLES OF INCORPORATION, AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON REQUEST, CONTACT INFO@NWKIDNEY.ORG. THE FISCAL YEAR FINANCIAL RESULTS ARE PUBLISHED IN THE ANNUAL REPORT, AVAILABLE ON WWW.NWKIDNEY.ORG. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT 149,181.